CD274 and hepatocellular carcinoma: In addition, due to a shortage of data on HCC patients undergoing anti-PD-L1 medication, the IMvigor210 database was utilized as an external anti-PD-L1 cohort to investigate the possible predictive usefulness of the Tregs-related signature.